← Back to signals
SHC
LONGINSIDER SELLSOTERA HEALTH CO
Funds
3
Score
4.50
vs SPY
-7.3%
Stock return (since Q-end)
+9.1%
SPY return (since Q-end)
+16.3%
Current price
$15.64
News Summary
NeutralSotera Health delivered solid Q1 2026 results with 10% revenue growth and 29% Adjusted EPS growth, reaffirming full-year guidance for 5-6.5% constant-currency growth. However, the company faces material headwinds including ~140 pending EtO personal injury/wrongful death claims with trials in early 2027, a highly leveraged 3.2x net leverage ratio, and ongoing EPA regulatory uncertainty around emissions standards that could impact sterilization operations.
Red flags
- •140 personal injury/wrongful death EtO claims pending in Los Angeles County with trials scheduled January-April 2027 — significant litigation overhang
- •3.2x net leverage ratio with $135-145M annual interest expense limits financial flexibility despite $900M+ liquidity
- •Insurance coverage disputes reversed by Seventh Circuit (March 2026) — reduced coverage for historical EtO liabilities increases company exposure
- •EPA reconsidering 2024 ethylene oxide emissions standards as of April 2026 — regulatory environment remains uncertain and could impose operational/cost impacts
- •Nelson Labs segment showing weakness with slight revenue decline; minimal Q2 growth expected
- •New CEO transition (May 26, 2026) introduces execution risk during period of significant litigation and regulatory uncertainty
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | QoQ | Status |
|---|---|---|---|---|---|---|
| Sachem Head Capital | Scott Ferguson | 11.6M | +11.6M | $167.0B | — | NEW |
| Greenlight Capital | David Einhorn | 2.1M | +2.1M | $29.6B | — | NEW |
| Point72 | Steve Cohen | 1.6M | +1.6M | $23.1B | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|
| WARBURG PINCUS & CO. | — | SELL | 19.1M | $15.17 | $289.75M | 2026-05-13 |
| WARBURG PINCUS & CO. | — | SELL | 19.1M | $15.17 | $289.75M | 2026-05-13 |
| GTCR INVESTMENT XI LLC | — | SELL | 12.7M | $15.17 | $193.17M | 2026-05-13 |